3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thrombosis
2
Venous Thromboembolism
2
Pulmonary Embolism
2
Neoplasms
2
Urinary Bladder Neoplasms
1
Thrombosis
1
Thromboembolism
1
Stroke
1
Soft Tissue Neoplasms
1
Sarcoma
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hemorrhage
1
Hematologic Neoplasms
1
Anastomotic Leak
1
Interventions
Cyclophosphamide
21
fludarabine phosphate
13
Cyclosporine
11
Antilymphocyte Serum
11
Peripheral Blood Stem Cell Transplantation
10
Methotrexate
10
Busulfan
10
Cytarabine
9
Filgrastim
8
Radiotherapy
7
Dexamethasone
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Methylprednisolone
6
Melphalan
6
Exercise
6
fludarabine
5
Vincristine
5
Daunorubicin
5
Cord Blood Stem Cell Transplantation
5
pegaspargase
4
Rituximab
4
Palliative Care
4
Mercaptopurine
4
Etoposide
4
Early Intervention, Educational
4
Blood Specimen Collection
4
Asparaginase
4
Alemtuzumab
4
Thioguanine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia
×
Enoxaparin
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled